$ARIA Headlines Apple gains on China Mobile deal
Post# of 72711
Posted On: 12/23/2013 1:53:29 PM
$ARIA Headlines
Apple gains on China Mobile deal; homebuilders rally 12:22 p.m. Today - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Today - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Credit Suisse raises target but still cautious on Ariad Pharma 51 min ago - Seeking Alpha
UPDATE: Credit Suisse Raises PT on Ariad Pharmaceuticals, View Remains Cautious 9:27 a.m. Today - benzinga.com
Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA) 9:24 a.m. Today - TheStreet.com
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Today - Seeking Alpha
Don't Buy Ariad Pharmaceuticals Shares At These Levels 8:30 a.m. Today - Seeking Alpha
Ariad rises as sell-side weighs in on new label for Iclusig 8:23 a.m. Today - Seeking Alpha
UPDATE: Bank of America Reiterates on Ariad Pharmaceuticals Following News of Iclusig Re-Launch 8:16 a.m. Today - benzinga.com
Ariad Pharmaceuticals Catches Fire 7:51 a.m. Today - TheStreet.com
UPDATE: Credit Suisse Reiterates on Ariad Pharmaceuticals as Iclusig Re-Launch is Expected to be Bumpy 7:48 a.m. Today - benzinga.com
Benzinga's Top Upgrades 7:48 a.m. Today - benzinga.com
Top Analyst Upgrades and Downgrades: BlackBerry, Five Below, Micron, Tiffany and More 7:45 a.m. Today - 247WallSt.com
Ariad to Resume Selling Iclusig in U.S. 3:18 p.m. Dec. 20, 2013 - WSJ.com
4 Biotech Stocks on the Move 1:14 p.m. Dec. 20, 2013 - Wall St. Cheat Sheet
Why Ariad Pharmaceuticals (ARIA) is Soaring 1:06 p.m. Dec. 20, 2013 - TheStreet.com
ARIAD Resumes Marketing and Distribution of Iclusig, Investors Getting Some Relief? 12:25 p.m. Dec. 20, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Showing Unusual Social Activity Today 10:29 a.m. Dec. 20, 2013 - TheStreet.com
Ariad's Iclusig set for market return after FDA approves revised USPI and REMS 10:20 a.m. Dec. 20, 2013 - Seeking Alpha
Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Perilous Reversal" Stock 9:47 a.m. Dec. 19, 2013 - TheStreet.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
Cowen Forecasts Top 10 Potential Biotech Surprises for 2014 7:37 a.m. Dec. 19, 2013 - 247WallSt.com
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Today - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Today - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Today - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 7:35 a.m. Dec. 3, 2013 - BusinessWire
TrendingWallStreet.com Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
ARIA, AAPL, EBAY and CAMT added to NASDAQ Active Stock Watch List at EPR 10:34 a.m. Dec. 2, 2013 - ACCESSWIRE
Traders Buzz: Tesla Motors Inc, Sirius XM Radio, Microsoft Corporation, Ariad Pharmaceuticals 9:35 a.m. Dec. 2, 2013 - ACCESSWIRE
Apple gains on China Mobile deal; homebuilders rally 12:22 p.m. Today - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Today - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Credit Suisse raises target but still cautious on Ariad Pharma 51 min ago - Seeking Alpha
UPDATE: Credit Suisse Raises PT on Ariad Pharmaceuticals, View Remains Cautious 9:27 a.m. Today - benzinga.com
Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA) 9:24 a.m. Today - TheStreet.com
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Today - Seeking Alpha
Don't Buy Ariad Pharmaceuticals Shares At These Levels 8:30 a.m. Today - Seeking Alpha
Ariad rises as sell-side weighs in on new label for Iclusig 8:23 a.m. Today - Seeking Alpha
UPDATE: Bank of America Reiterates on Ariad Pharmaceuticals Following News of Iclusig Re-Launch 8:16 a.m. Today - benzinga.com
Ariad Pharmaceuticals Catches Fire 7:51 a.m. Today - TheStreet.com
UPDATE: Credit Suisse Reiterates on Ariad Pharmaceuticals as Iclusig Re-Launch is Expected to be Bumpy 7:48 a.m. Today - benzinga.com
Benzinga's Top Upgrades 7:48 a.m. Today - benzinga.com
Top Analyst Upgrades and Downgrades: BlackBerry, Five Below, Micron, Tiffany and More 7:45 a.m. Today - 247WallSt.com
Ariad to Resume Selling Iclusig in U.S. 3:18 p.m. Dec. 20, 2013 - WSJ.com
4 Biotech Stocks on the Move 1:14 p.m. Dec. 20, 2013 - Wall St. Cheat Sheet
Why Ariad Pharmaceuticals (ARIA) is Soaring 1:06 p.m. Dec. 20, 2013 - TheStreet.com
ARIAD Resumes Marketing and Distribution of Iclusig, Investors Getting Some Relief? 12:25 p.m. Dec. 20, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Showing Unusual Social Activity Today 10:29 a.m. Dec. 20, 2013 - TheStreet.com
Ariad's Iclusig set for market return after FDA approves revised USPI and REMS 10:20 a.m. Dec. 20, 2013 - Seeking Alpha
Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Perilous Reversal" Stock 9:47 a.m. Dec. 19, 2013 - TheStreet.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
Cowen Forecasts Top 10 Potential Biotech Surprises for 2014 7:37 a.m. Dec. 19, 2013 - 247WallSt.com
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Today - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Today - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Today - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 7:35 a.m. Dec. 3, 2013 - BusinessWire
TrendingWallStreet.com Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
ARIA, AAPL, EBAY and CAMT added to NASDAQ Active Stock Watch List at EPR 10:34 a.m. Dec. 2, 2013 - ACCESSWIRE
Traders Buzz: Tesla Motors Inc, Sirius XM Radio, Microsoft Corporation, Ariad Pharmaceuticals 9:35 a.m. Dec. 2, 2013 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼